These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 16580499)
21. Improvement of esophageal adenocarcinoma cell and xenograft responses to radiation by targeting cyclin-dependent kinases. Raju U; Ariga H; Koto M; Lu X; Pickett J; Valdecanas D; Mason KA; Milas L Radiother Oncol; 2006 Aug; 80(2):185-91. PubMed ID: 16905211 [TBL] [Abstract][Full Text] [Related]
22. Resistance of prostate cancer cells to soluble TNF-related apoptosis-inducing ligand (TRAIL/Apo2L) can be overcome by doxorubicin or adenoviral delivery of full-length TRAIL. Voelkel-Johnson C; King DL; Norris JS Cancer Gene Ther; 2002 Feb; 9(2):164-72. PubMed ID: 11857034 [TBL] [Abstract][Full Text] [Related]
23. Cisplatin-dependent upregulation of death receptors 4 and 5 augments induction of apoptosis by TNF-related apoptosis-inducing ligand against esophageal squamous cell carcinoma. Kondo K; Yamasaki S; Sugie T; Teratani N; Kan T; Imamura M; Shimada Y Int J Cancer; 2006 Jan; 118(1):230-42. PubMed ID: 16003725 [TBL] [Abstract][Full Text] [Related]
24. A tumor-targeted and conditionally replicating oncolytic adenovirus vector expressing TRAIL for treatment of liver metastases. Sova P; Ren XW; Ni S; Bernt KM; Mi J; Kiviat N; Lieber A Mol Ther; 2004 Apr; 9(4):496-509. PubMed ID: 15093180 [TBL] [Abstract][Full Text] [Related]
25. Potential mechanism of resistance to TRAIL-induced apoptosis in Burkitt's lymphoma. Tafuku S; Matsuda T; Kawakami H; Tomita M; Yagita H; Mori N Eur J Haematol; 2006 Jan; 76(1):64-74. PubMed ID: 16343273 [TBL] [Abstract][Full Text] [Related]
26. A tumor-specific conditionally replicative adenovirus vector expressing TRAIL for gene therapy of hepatocellular carcinoma. Ren XW; Liang M; Meng X; Ye X; Ma H; Zhao Y; Guo J; Cai N; Chen HZ; Ye SL; Hu F Cancer Gene Ther; 2006 Feb; 13(2):159-68. PubMed ID: 16082383 [TBL] [Abstract][Full Text] [Related]
27. Direct stimulation of apoptotic signaling by soluble Apo2l/tumor necrosis factor-related apoptosis-inducing ligand leads to selective killing of glioma cells. Pollack IF; Erff M; Ashkenazi A Clin Cancer Res; 2001 May; 7(5):1362-9. PubMed ID: 11350907 [TBL] [Abstract][Full Text] [Related]
28. Ionizing radiation enhances the therapeutic potential of TRAIL in prostate cancer in vitro and in vivo: Intracellular mechanisms. Shankar S; Singh TR; Srivastava RK Prostate; 2004 Sep; 61(1):35-49. PubMed ID: 15287092 [TBL] [Abstract][Full Text] [Related]
29. Augmentation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by the synthetic retinoid 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphthalene carboxylic acid (CD437) through up-regulation of TRAIL receptors in human lung cancer cells. Sun SY; Yue P; Hong WK; Lotan R Cancer Res; 2000 Dec; 60(24):7149-55. PubMed ID: 11156424 [TBL] [Abstract][Full Text] [Related]
30. Synergistic induction of apoptosis by the combination of trail and chemotherapy in chemoresistant ovarian cancer cells. Cuello M; Ettenberg SA; Nau MM; Lipkowitz S Gynecol Oncol; 2001 Jun; 81(3):380-90. PubMed ID: 11371126 [TBL] [Abstract][Full Text] [Related]
31. Adenovirus-TRAIL can overcome TRAIL resistance and induce a bystander effect. Seol JY; Park KH; Hwang CI; Park WY; Yoo CG; Kim YW; Han SK; Shim YS; Lee CT Cancer Gene Ther; 2003 Jul; 10(7):540-8. PubMed ID: 12833134 [TBL] [Abstract][Full Text] [Related]
32. Adeno-associated virus-mediated gene transfer of a secreted form of TRAIL inhibits tumor growth and occurrence in an experimental tumor model. Yoo J; Choi S; Hwang KS; Cho WK; Jung CR; Kwon ST; Im DS J Gene Med; 2006 Feb; 8(2):163-74. PubMed ID: 16144019 [TBL] [Abstract][Full Text] [Related]
33. The sequential treatment with ionizing radiation followed by TRAIL/Apo-2L reduces tumor growth and induces apoptosis of breast tumor xenografts in nude mice. Shankar S; Singh TR; Chen X; Thakkar H; Firnin J; Srivastava RK Int J Oncol; 2004 May; 24(5):1133-40. PubMed ID: 15067334 [TBL] [Abstract][Full Text] [Related]
34. Human melanoma cells selected for resistance to apoptosis by prolonged exposure to tumor necrosis factor-related apoptosis-inducing ligand are more vulnerable to necrotic cell death induced by cisplatin. Zhang XD; Wu JJ; Gillespie S; Borrow J; Hersey P Clin Cancer Res; 2006 Feb; 12(4):1355-64. PubMed ID: 16489094 [TBL] [Abstract][Full Text] [Related]
35. Combined gene therapy and ionizing radiation is a novel approach to treat human esophageal adenocarcinoma. Gupta VK; Park JO; Jaskowiak NT; Mauceri HJ; Seetharam S; Weichselbaum RR; Posner MC Ann Surg Oncol; 2002 Jun; 9(5):500-4. PubMed ID: 12052763 [TBL] [Abstract][Full Text] [Related]
36. Conditionally replicating adenovirus combined with gene-targeted radiotherapy induces apoptosis via TRAIL death receptors in MDA-MB-231 cells. Wu JH; Wang HF; Wang ZC; Xu K; Qi YL; Li JH; Gong SL; Liu Y; Liu Y Mol Med Rep; 2013 Jul; 8(1):299-305. PubMed ID: 23708314 [TBL] [Abstract][Full Text] [Related]
37. An oncolytic adenoviral vector of Smac increases antitumor activity of TRAIL against HCC in human cells and in mice. Pei Z; Chu L; Zou W; Zhang Z; Qiu S; Qi R; Gu J; Qian C; Liu X Hepatology; 2004 May; 39(5):1371-81. PubMed ID: 15122766 [TBL] [Abstract][Full Text] [Related]
38. Enhanced apoptosis of glioma cell lines is achieved by co-delivering FasL-GFP and TRAIL with a complex Ad5 vector. Rubinchik S; Yu H; Woraratanadharm J; Voelkel-Johnson C; Norris JS; Dong JY Cancer Gene Ther; 2003 Nov; 10(11):814-22. PubMed ID: 14605667 [TBL] [Abstract][Full Text] [Related]
39. Tumor necrosis factor-related apoptosis-inducing ligand gene on human colorectal cancer cell line HT29. Xu XM; He C; Hu XT; Fang BL World J Gastroenterol; 2003 May; 9(5):965-9. PubMed ID: 12717839 [TBL] [Abstract][Full Text] [Related]
40. An adenovirus encoding proapoptotic Bax induces apoptosis and enhances the radiation effect in human ovarian cancer. Arafat WO; Gómez-Navarro J; Xiang J; Barnes MN; Mahasreshti P; Alvarez RD; Siegal GP; Badib AO; Buchsbaum D; Curiel DT; Stackhouse MA Mol Ther; 2000 Jun; 1(6):545-54. PubMed ID: 10933979 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]